Craig Gordon

Investment Analyst
The Capital Group Companies, Inc.

Craig Gordon is an equity investment analyst at Capital Group with research responsibility for U.S. and Japanese biotechnology and pharmaceutical companies. Gordon has eight years of investment experience and has been with Capital Group for six years. He is based in Los Angeles.

Prior to joining Capital Group, Gordon was a biotechnology equity research analyst and associate for the Cowen Group in New York.

Gordon holds a Master of Business Administration degree from Duke University’s Fuqua School of Business, a doctor of medicine (with research distinction) and Medical Resident Teaching Award from the University of Miami, Miller School of Medicine and Jackson Memorial Hospital, respectively. Gordon holds a bachelor’s degree (with distinction) in economics from Cornell University. He completed his rheumatology training at Duke Medical Center.